US Equities
Cleveland BioLabs (CBLI) Escalates on Merger Agreement with Cytocom
Cleveland will combine with Cytocom in an all-stock transaction. Cleveland BioLabs, Inc. (CBLI) shares are spiking today after it was reported that the company has signed a definitive merger agreement with, a leading biopharmaceutical company in the area of immune-modulation, Cytocom, Inc. Shares of Cleveland
